T1	Participants 574 643	Two hundred patients with similar demographics undergoing elective LC
T2	Participants 856 995	All patients received preperitoneal abdominal wall infiltration with 0.25 per cent bupivacaine to control parietal (somatic) abdominal pain
T3	Participants 1329 1351	Patients in each group
T4	Participants 1609 1621	all patients
